Immersive virtual reality reduces depression, anxiety and stress in patients with cardiovascular diseases undergoing cardiac rehabilitation: A systematic review with meta-analysis

IF 2.4 4区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Heart & Lung Pub Date : 2024-12-07 DOI:10.1016/j.hrtlng.2024.11.018

Irene Cortés-Pérez , Esteban Obrero-Gaitán , Alberto Verdejo-Herrero , Noelia Zagalaz-Anula , Raúl Romero-del-Rey , Héctor García-López

{"title":"Immersive virtual reality reduces depression, anxiety and stress in patients with cardiovascular diseases undergoing cardiac rehabilitation: A systematic review with meta-analysis","authors":"Irene Cortés-Pérez , Esteban Obrero-Gaitán , Alberto Verdejo-Herrero , Noelia Zagalaz-Anula , Raúl Romero-del-Rey , Héctor García-López","doi":"10.1016/j.hrtlng.2024.11.018","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Current literature suggests that immersive virtual reality (IVR) could be an efficacious therapeutic approach for patients with cardiovascular diseases (CVD) undergoing cardiac rehabilitation program (CRP). However, this has only been affirmed in individual studies and is yet to be confirmed by a systematic review.</div></div><div><h3>Objectives</h3><div>To determine the efficacy of IVR interventions on depression, anxiety, and stress symptoms in patients with CVD.</div></div><div><h3>Methods</h3><div>A meta-analysis was performed in line with PRISMA guidelines following a literature search between inception and June 2024 in PubMed, SCOPUS, WOS, CINAHL and PEDro for retrieving randomized controlled trials (RCTs) that compared the efficacy of IVR versus conventional CRPs on depression, anxiety and stress in patients with CVD. The PEDro scale was used to evaluate the methodological quality of the studies. Pooled effects were calculated using the Cohen's standardized mean difference (SMD) and its 95% confidence interval (95% CI), or mean difference (MD) if studies used the same measure.</div></div><div><h3>Results</h3><div>Eight RCTs, providing data from 510 patients with CVD (63.8±5.4 years, 60% men), were included. The methodological quality was moderate (M=5.1±1 points). A large rehabilitative effect of IVR was found for reducing depression (SMD=-0.54; 95% CI -0.77 to -0.31; p<0.001), anxiety (SMD=-0.43; 95% CI -0.74 to -0.12; p=0.006) and stress (MD=-14.96; 95% CI -20.1 to -9.8; p<0.001). The findings suggest that combine IVR and CRP is the most appropriate approach for reducing depression, anxiety and stress.</div></div><div><h3>Conclusion</h3><div>IVR, especially when combined with a traditional CRP, reduces depression, anxiety and stress in patients with CVD.</div></div>","PeriodicalId":55064,"journal":{"name":"Heart & Lung","volume":"70 ","pages":"Pages 102-111"},"PeriodicalIF":2.4000,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart & Lung","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0147956324002425","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Current literature suggests that immersive virtual reality (IVR) could be an efficacious therapeutic approach for patients with cardiovascular diseases (CVD) undergoing cardiac rehabilitation program (CRP). However, this has only been affirmed in individual studies and is yet to be confirmed by a systematic review.

Objectives

To determine the efficacy of IVR interventions on depression, anxiety, and stress symptoms in patients with CVD.

Methods

A meta-analysis was performed in line with PRISMA guidelines following a literature search between inception and June 2024 in PubMed, SCOPUS, WOS, CINAHL and PEDro for retrieving randomized controlled trials (RCTs) that compared the efficacy of IVR versus conventional CRPs on depression, anxiety and stress in patients with CVD. The PEDro scale was used to evaluate the methodological quality of the studies. Pooled effects were calculated using the Cohen's standardized mean difference (SMD) and its 95% confidence interval (95% CI), or mean difference (MD) if studies used the same measure.

Results

Eight RCTs, providing data from 510 patients with CVD (63.8±5.4 years, 60% men), were included. The methodological quality was moderate (M=5.1±1 points). A large rehabilitative effect of IVR was found for reducing depression (SMD=-0.54; 95% CI -0.77 to -0.31; p<0.001), anxiety (SMD=-0.43; 95% CI -0.74 to -0.12; p=0.006) and stress (MD=-14.96; 95% CI -20.1 to -9.8; p<0.001). The findings suggest that combine IVR and CRP is the most appropriate approach for reducing depression, anxiety and stress.

Conclusion

IVR, especially when combined with a traditional CRP, reduces depression, anxiety and stress in patients with CVD.

查看原文本刊更多论文

沉浸式虚拟现实技术可减少接受心脏康复治疗的心血管疾病患者的抑郁、焦虑和压力：系统综述与荟萃分析。

背景：现有文献表明，沉浸式虚拟现实（IVR）对接受心脏康复计划（CRP）的心血管疾病（CVD）患者来说是一种有效的治疗方法。然而，这仅在个别研究中得到证实，尚待系统性综述确认：确定 IVR 干预对心血管疾病患者抑郁、焦虑和压力症状的疗效：根据PRISMA指南，我们在PubMed、SCOPUS、WOS、CINAHL和PEDro上检索了从开始到2024年6月期间的文献，比较了IVR与传统CRP对心血管疾病患者抑郁、焦虑和压力的疗效，并根据PRISMA指南进行了荟萃分析。PEDro 量表用于评估研究的方法学质量。使用科恩标准化平均差（SMD）及其95%置信区间（95% CI）或平均差（MD）（如果研究使用相同的测量方法）计算汇总效应：共纳入了 8 项研究，提供了 510 名心血管疾病患者（63.8±5.4 岁，60% 为男性）的数据。方法学质量为中等（M=5.1±1 分）。IVR对减少抑郁有很大的康复效果（SMD=-0.54；95% CI -0.77至-0.31；p 结论：IVR，尤其是与传统的 CRP 结合使用时，可减少心血管疾病患者的抑郁、焦虑和压力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Heart & Lung 医学-呼吸系统

CiteScore

4.60

自引率

3.60%

发文量

184

审稿时长

35 days

期刊介绍： Heart & Lung: The Journal of Cardiopulmonary and Acute Care, the official publication of The American Association of Heart Failure Nurses, presents original, peer-reviewed articles on techniques, advances, investigations, and observations related to the care of patients with acute and critical illness and patients with chronic cardiac or pulmonary disorders. The Journal''s acute care articles focus on the care of hospitalized patients, including those in the critical and acute care settings. Because most patients who are hospitalized in acute and critical care settings have chronic conditions, we are also interested in the chronically critically ill, the care of patients with chronic cardiopulmonary disorders, their rehabilitation, and disease prevention. The Journal''s heart failure articles focus on all aspects of the care of patients with this condition. Manuscripts that are relevant to populations across the human lifespan are welcome.